STROMUSC Premium RAD140 10mg For Bodybuilding CAS:1182367-47-0
In the evolving landscape of physique enhancement, Selective Androgen Receptor Modulators (SARMs) have carved a distinct niche, positioned between traditional anabolic-androgenic steroids (AAS) and benign supplements. Among these, RAD-140, codenamed Testolone, has emerged as a compound of significant interest and controversy. This analysis delves into the intricacies of RAD-140, specifically at the commonly utilized 10mg dosage, providing a detailed, objective, and novel perspective for the educated bodybuilder. It is imperative to preface this discussion with a critical disclaimer: RAD-140 is an unapproved research chemical, not a dietary supplement. Its human safety profile is not fully established, and possession or use may violate sporting regulations and local laws.
What is RAD-140? Beyond the SARM Label
RAD-140 is a novel, non-steroidal therapeutic candidate initially developed for conditions like muscle wasting and breast cancer. Its design philosophy aimed to mimic the anabolic (muscle-building) effects of testosterone while minimizing the androgenic (male-characteristic) side effects-a concept termed tissue selectivity. Unlike traditional steroids, which are based on a cholesterol-derived steroidal backbone, RAD-140 is a structurally distinct synthetic molecule that binds with high affinity and selectivity to the androgen receptor (AR).
A unique and often underreported facet of RAD-140 is its proposed neuroprotective activity. Early research suggested it could promote the growth and survival of neuronal cells, a feature that sparked interest in neurodegenerative diseases. While this is rarely the focus in bodybuilding circles, it hints at the compound's complex mechanism of action, which may extend beyond skeletal muscle. Its "SARM" classification, while useful, can be an oversimplification of its multifaceted interaction with the body's endocrine and nervous systems.
Distinctive Features and Pharmacological Profile
The appeal of RAD-140 lies in its specific feature set, which differentiates it from both steroids and other SARMs:
1.High Anabolic Ratio: Preclinical data indicates an exceptionally high anabolic-to-androgenic ratio. In model systems, it demonstrates potent muscle-building activity with markedly less stimulation of secondary sexual organs (like the prostate) compared to testosterone. This is the theoretical foundation for its "milder" side-effect profile.
2.Androgen Receptor Full Agonism: Unlike some partial agonists, RAD-140 acts as a strong, full agonist at the AR in muscle and bone. This results in a pronounced androgenic signaling cascade, driving protein synthesis and nitrogen retention with notable potency.
3.Tissue-Selective Gene Expression: Its selectivity is not merely about "where" it binds, but what genetic programs it activates after binding. It appears to promote beneficial anabolic pathways in muscle while having a muted effect on genes responsible for androgenic side effects in other tissues-a nuance often missed in generic descriptions.
4.Absence of 5-alpha Reduction: Unlike testosterone, RAD-140 is not metabolized by the 5-alpha reductase enzyme into a more potent androgen (like DHT). This theoretically reduces the risk of androgenic alopecia and prostate enlargement, though individual genetic predispositions still play a role.
5.Potential Myostatin Inhibition: Anecdotal reports and some preliminary data suggest RAD-140 may downregulate myostatin, a protein that limits muscle growth. This dual action-direct AR stimulation plus suppression of a growth inhibitor-could explain its profound hypertrophic effects.
Applications in a Bodybuilding Context
The application of RAD-140 extends beyond mere "bulking." Informed users deploy it strategically:
●Lean Mass Accretion: Its primary use is for adding substantial, quality muscle mass with minimal fluid retention, leading to a "dry," hard, and vascular appearance.
●Recomposition: At a dose like 10mg daily, coupled with a caloric maintenance or slight deficit, RAD-140 can facilitate significant fat loss while preserving or even increasing lean tissue, making it a powerful tool for "cutting" or recomposition phases.
●Strength Catalyst: Users consistently report rapid and substantial increases in strength, leverage, and gym performance, often outpacing visible muscular growth. This makes it valuable for powerlifters and athletes in strength-dominant phases.
●Injury Rehabilitation Support: Its anabolic effect on bone and connective tissue, combined with muscle-sparing properties, has led to off-label interest for rehabilitating musculoskeletal injuries, though this is purely anecdotal and requires extreme caution.
Reported Benefits and Realistic Expectations
At a 10mg daily dose, users report a suite of benefits that typically manifest within 2-3 weeks:
●Pronounced Muscle Hardness and Density: Gains are notably non-aqueous, enhancing muscular definition.
●Accelerated Recovery: Reduced DOMS (Delayed Onset Muscle Soreness) and the ability to sustain higher training frequency and volume.
●Enhanced Cognitive Focus: Anecdotally linked to its neuroprotective research, users often describe a heightened sense of mental clarity, drive, and aggression in training sessions.
●Increased Vascularity: Due to reduced subcutaneous water and improved muscle fullness.
Crucial Realism: These benefits are not guaranteed and come with potential trade-offs. The term "anabolic without androgenic" is a pharmacological ideal, not a clinical reality for all users. Androgenic side effects can and do occur, including suppression of natural testosterone production, which is a near-certainty at 10mg over a cycle length.
Dosage, Cycle Architecture, and Half-Life
●Dosage (10mg): 10mg per day is widely considered the "sweet spot" for balancing efficacy and side-effect management. It is a moderate-to-high dose. Novices often start at 5-10mg; exceeding 20mg daily yields diminishing returns and exponentially increases the risk of side effects and suppression.
●Cycle Length: A typical cycle lasts 8-12 weeks. Shorter cycles (6-8 weeks) at 10mg can be effective for recomp, while longer cycles (12 weeks) are often employed for mass gains. Extending beyond 12 weeks significantly heightens the risk of profound suppression and hepatotoxicity.
●Half-Life: RAD-140 has a terminal half-life of approximately 16-20 hours. This is a critical pharmacokinetic property. It means the compound maintains stable blood levels with once-daily dosing, but more importantly, it dictates the necessity of a Post-Cycle Therapy (PCT) timing strategy. Due to its long half-life, waiting 3-5 days after the last dose before initiating PCT allows for sufficient clearance, ensuring the SERMs (Selective Estrogen Receptor Modulators) used in PCT are not competing with residual RAD-140 for the hypothalamic AR.
The Imperative of Post-Cycle Therapy (PCT)
Natural testosterone production is almost certainly suppressed after an 8-12 week cycle of RAD-140 at 10mg/day. The hypothalamus and pituitary gland (the HPTA axis) sense the exogenous androgenic activity and shut down endogenous production. PCT is not optional; it is a critical recovery protocol.
A standard PCT begins 3-5 days after the last RAD-140 dose and lasts 4-6 weeks. It typically involves:
●A SERM like Enclomiphene (12.5mg/day) or Nolvadex (Tamoxifen, 10-20mg/day): These block estrogen receptors in the pituitary, spurring the release of LH and FSH to restart the testes' testosterone production.
●Supportive Supplements: Compounds like D-Aspartic Acid, Ashwagandha, and robust Zinc/Magnesium/Vitamin D3 intake can provide ancillary support, but they cannot replace SERM therapy.
Blood work (before, during if possible, and after PCT) is the only objective measure of recovery. Assumptions about being "shut down" or "recovered" without blood tests are speculative and risky.
A Novel Perspective: The RAD-140 Paradox and Risk Reassessment
A unique consideration often omitted is the RAD-140 Paradox: its very potency and "clean" gains may lead to disproportionate structural risk. The rapid gains in strength and muscle density can outpace the adaptation of tendons, ligaments, and joints, which do not possess the same density of androgen receptors. This can create a biomechanical mismatch, increasing the risk of connective tissue injuries. Furthermore, its suppression can be deceptively severe; the lack of dramatic estrogenic side effects (like water retention or gynecomastia) can lull users into underestimating the degree of HPTA shutdown occurring beneath the surface.
Clinical Data
|
Brand |
STROMUSC |
|
Trade names |
RAD140; RAD-140; EP0062; testolone,Vosilasarm |
|
CAS |
1182367-47-0 |
|
Molar mass |
393.83 |
|
MF |
C20H16ClN5O2 |
|
Purity |
Above 98% |
|
Apprarance |
10mg*100 |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion
RAD-140 at 10mg/day represents a powerful, modern anabolic agent with a unique pharmacological profile. It offers the potential for impressive dry muscle gain, recomposition, and performance enhancement. However, it operates in a regulatory and medical gray zone, carrying unequivocal risks of endocrine disruption and unknown long-term effects. The informed individual must weigh its potent benefits against the certainty of suppression, the necessity of a disciplined PCT, and the acceptance of experimenting with an unresearched chemical. The pursuit of physical enhancement must be tempered with a respect for biological complexity and a commitment to measured, evidence-based recovery practices.
Hot Tags: stromusc premium rad140 10mg for bodybuilding cas:1182367-47-0, China stromusc premium rad140 10mg for bodybuilding cas:1182367-47-0 manufacturers, suppliers, factory, Sarm Powders, GW0742, Andarine S4 Build muscle, RAD140, LGD3303, SR9009 Hormone and Metabolic Regulators
